Impact Factor 2.889 | CiteScore 3.1

More on impact ›


Front. Neurol., 23 October 2019 |

Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS

Greig Joilin1*, P. Nigel Leigh2, Sarah F. Newbury2 and Majid Hafezparast1*
  • 1School of Life Sciences, University of Sussex, Brighton, United Kingdom
  • 2Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom

A Corrigendum on
An Overview of MicroRNAs as Biomarkers of ALS

by Joilin, G., Leigh, P. N., Newbury, S. F., and Hafezparast, M. (2019). Front. Neurol. 10:186. doi: 10.3389/fneur.2019.00186

In the original article, there was a mistake in Table 1 as published. Some of the miRNAs listed in the table were incorrectly placed in the wrong column and/or row. The corrected Table 1 appears below.


Table 1. Circulating miRNA-based biomarkers found to be differentially expressed in biofluids.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: amyotrophic lateral sclerosis, motor neuron disease, biomarkers, non-coding RNA, microRNA

Citation: Joilin G, Leigh PN, Newbury SF and Hafezparast M (2019) Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS. Front. Neurol. 10:1129. doi: 10.3389/fneur.2019.01129

Received: 07 October 2019; Accepted: 09 October 2019;
Published: 23 October 2019.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Joilin, Leigh, Newbury and Hafezparast. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Greig Joilin,; Majid Hafezparast,